Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Osborne

Showing results (341-350 of 354) with videos related to

Pageof 36
Sort By:
Nature Communications|December 3, 2021
Spatiotemporal dynamics of SETD5-containing NCoR-HDAC3 complex determines enhancer activation for adipogenesisYoshihiro Matsumura, Ryo Ito, Ayumu Yajima, et al.
The British Journal of Ophthalmology|January 14, 2026
Orbital inflammation in VEXAS syndromeClare Quigley, James Pietris, Terence Ang, et al.
JCI Insight|July 21, 2020
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infectionsKenneth E Remy, Monty Mazer, David A Striker, et al.
Health Services Research|June 6, 2025
Veteran Mental Health Emergency Care Utilization Following SARS-CoV-2 InfectionJason I Chen, Meike Niederhausen, David P Bui, et al.
Plos One|June 24, 2014
Genetic deletion of transglutaminase 2 does not rescue the phenotypic deficits observed in R6/2 and zQ175 mouse models of Huntington's diseaseLiliana B Menalled, Andrea E Kudwa, Steve Oakeshott, et al.
Nature Communications|December 13, 2023
Enhanced SREBP2-driven cholesterol biosynthesis by PKCλ/ι deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesisYu Muta, Juan F Linares, Anxo Martinez-Ordoñez, et al.
Journal of General Internal Medicine|October 26, 2023
Risk of Suicide-Related Outcomes After SARS-COV-2 Infection: Results from a Nationwide Observational Matched Cohort of US VeteransDenise M Hynes, Meike Niederhausen, Jason I Chen, et al.
Ebiomedicine|April 21, 2018
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical ModelsRyan M Esquejo, Christopher T Salatto, Jake Delmore, et al.
Scientific Reports|October 29, 2017
Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease miceMarie K Bondulich, Nelly Jolinon, Georgina F Osborne, et al.
Nature Protocols|May 6, 2021
Use of deep learning to develop continuous-risk models for adverse event prediction from electronic health recordsNenad Tomašev, Natalie Harris, Sebastien Baur, et al.
Pageof 36

Showing results (341-350 of 354) with videos related to

Sort By:
Pageof 36
Nature Communications|December 3, 2021
Spatiotemporal dynamics of SETD5-containing NCoR-HDAC3 complex determines enhancer activation for adipogenesisYoshihiro Matsumura, Ryo Ito, Ayumu Yajima, et al.
The British Journal of Ophthalmology|January 14, 2026
Orbital inflammation in VEXAS syndromeClare Quigley, James Pietris, Terence Ang, et al.
JCI Insight|July 21, 2020
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infectionsKenneth E Remy, Monty Mazer, David A Striker, et al.
Health Services Research|June 6, 2025
Veteran Mental Health Emergency Care Utilization Following SARS-CoV-2 InfectionJason I Chen, Meike Niederhausen, David P Bui, et al.
Plos One|June 24, 2014
Genetic deletion of transglutaminase 2 does not rescue the phenotypic deficits observed in R6/2 and zQ175 mouse models of Huntington's diseaseLiliana B Menalled, Andrea E Kudwa, Steve Oakeshott, et al.
Nature Communications|December 13, 2023
Enhanced SREBP2-driven cholesterol biosynthesis by PKCλ/ι deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesisYu Muta, Juan F Linares, Anxo Martinez-Ordoñez, et al.
Journal of General Internal Medicine|October 26, 2023
Risk of Suicide-Related Outcomes After SARS-COV-2 Infection: Results from a Nationwide Observational Matched Cohort of US VeteransDenise M Hynes, Meike Niederhausen, Jason I Chen, et al.
Ebiomedicine|April 21, 2018
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical ModelsRyan M Esquejo, Christopher T Salatto, Jake Delmore, et al.
Scientific Reports|October 29, 2017
Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease miceMarie K Bondulich, Nelly Jolinon, Georgina F Osborne, et al.
Nature Protocols|May 6, 2021
Use of deep learning to develop continuous-risk models for adverse event prediction from electronic health recordsNenad Tomašev, Natalie Harris, Sebastien Baur, et al.
Pageof 36